Company Quick10K Filing
IMAX
10-Q 2020-09-30 Filed 2020-10-29
10-Q 2020-06-30 Filed 2020-07-28
10-Q 2020-03-31 Filed 2020-04-30
10-K 2019-12-31 Filed 2020-02-19
10-Q 2019-09-30 Filed 2019-10-31
10-Q 2019-06-30 Filed 2019-07-30
10-Q 2019-03-31 Filed 2019-04-26
10-K 2018-12-31 Filed 2019-02-26
10-Q 2018-09-30 Filed 2018-10-25
10-Q 2018-06-30 Filed 2018-07-25
10-Q 2018-03-31 Filed 2018-05-01
10-K 2017-12-31 Filed 2018-02-27
10-Q 2017-09-30 Filed 2017-10-26
10-Q 2017-06-30 Filed 2017-07-26
10-Q 2017-03-31 Filed 2017-04-20
10-K 2016-12-31 Filed 2017-02-23
10-Q 2016-09-30 Filed 2016-10-20
10-Q 2016-06-30 Filed 2016-07-20
10-Q 2016-03-31 Filed 2016-04-21
10-K 2015-12-31 Filed 2016-02-24
10-Q 2015-09-30 Filed 2015-10-28
10-Q 2015-06-30 Filed 2015-07-23
10-Q 2015-03-31 Filed 2015-04-30
10-K 2014-12-31 Filed 2015-02-19
10-Q 2014-09-30 Filed 2014-10-23
10-Q 2014-06-30 Filed 2014-07-24
10-Q 2014-03-31 Filed 2014-04-24
10-K 2013-12-31 Filed 2014-02-20
10-Q 2013-09-30 Filed 2013-10-24
10-Q 2013-06-30 Filed 2013-07-25
10-Q 2013-03-31 Filed 2013-04-25
10-K 2012-12-31 Filed 2013-02-21
10-Q 2012-06-30 Filed 2012-07-26
10-Q 2012-03-31 Filed 2012-04-27
10-K 2011-12-31 Filed 2012-02-24
10-Q 2011-09-30 Filed 2011-10-27
10-Q 2011-06-30 Filed 2011-07-28
10-Q 2011-03-31 Filed 2011-04-28
10-K 2010-12-31 Filed 2011-02-24
10-Q 2010-09-30 Filed 2010-10-28
10-Q 2010-06-30 Filed 2010-07-29
10-Q 2010-03-31 Filed 2010-04-29
10-K 2009-12-31 Filed 2010-03-11
8-K 2020-10-29
8-K 2020-09-18
8-K 2020-07-28
8-K 2020-06-26
8-K 2020-06-10
8-K 2020-06-03
8-K 2020-04-30
8-K 2020-03-11
8-K 2020-02-19
8-K 2019-12-17
8-K 2019-11-20
8-K 2019-10-31
8-K 2019-10-30
8-K 2019-07-30
8-K 2019-06-05
8-K 2019-04-26
8-K 2019-02-26
8-K 2018-12-13
8-K 2018-10-25
8-K 2018-10-15
8-K 2018-07-25
8-K 2018-06-28
8-K 2018-06-05
8-K 2018-05-01
8-K 2018-03-23
8-K 2018-02-27

IMAX Financials

IMAX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546 323 0 0 0 0 -854
1 800 Flowers Com (FLWS) 944 42% 13.3 6% 665 336 1,266 534 37 75 1,001
10x Genomics (TXG) 4,805 75% -490.3 -2% 573 151 61 46 -10 -9 4,357
12 Retech (RETC) 0 32% -0.1 -1,385% 1 20 1 0 -15 -15 1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 34 0% 0.4 -5% 164 108 18 0 -8 -8 -3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 19 23 27 7 -3 -1 3
1895 Bancorp of Wisconsin (BCOW) 46,153 12,508.1 -0% 441 383 0 0 -0 4 46,142
1st Constitution Bancorp (FCCY) 165 0% 4.4 1% 1,343 1,204 0 0 14 33 144
1st Franklin Financial (FFC) 4 -0.6 7% 905 645 0 0 62 80 -46
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200 7.9 1% 6,691 5,858 0 0 70 136 1,073
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 2 0 0 -2 -2 0
21Vianet Group (VNET) 6,005 0% 11,151 5,788 0 0 0 0 3,344
22nd Century (XXII) 302 1% -14.1 -36% 62 7 26 0 -22 -21 302
1Life Healthcare (ONEM)

Balance Sheet ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash172319182224292115212630307594107140146117317260228218205190158158159146133134142123106103
Accounts Receivable314440474647364248634473607360766691889892958996969610313112011310693949182
Inventory18222021202116141314101417211726343639454551424541373129415345454858
PP&E78171180189195193190195206211220225239252267290305315326328336356362378388403421428439442276452302308305
Assets337372374406414425427422432454447481478538561622676727714931879867859857841840847867878870874874893876870
Accounts Payable
Long-Term Debt551130292828282726262625251838582318
Liabilities175201193213212206188169172177163162155157173195198208219254228240232231217258255263245257252274286265251
Stockholders' Equity162171181193202219239253260277284320323344350383394433407624596569568562561515520528549527537512516519527
Income Statement ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue455767675670817850825210448796110262107851199292871076988991268598821098010586
Cost of Revenue1131313729313635243924362231253926384321404142523338596534384054354539
Gross Profit2126363027394542264427682648356436694272525045553649406051604255456047
R&D2222333445444355523343454656444111
SG&A10
Tax-0251147015110351814928123377641853-1-453
Net Income-12863111513312228114521126112212114120239121784121411
Cash Flow ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-10-14131093420-192522142137156122342531933-1382622153121-14919
Cash Investing-4-14-14-31-10-9-4-12-13-5-9-15-14-15-17-17-28-21-16-14-9-22-8-26-14-17-26-16-12-7-14-28-15-11
Cash Financing12161832-24-1681-10-3-039-1155615-37171-53-41-12-190-53-1-4-17-37-610-51-12